PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER INCIDENCE IN PRE-VACCINATION AND THE INITIAL VACCINATION PERIODS IN THE REPUBLIC OF SAKHA (YAKUTIA)

被引:0
作者
Ignatieva, M. E.
Lyalina, L., V
Smetanina, V. D.
Karpova, I. I.
Afanasieva, L. N.
机构
来源
YAKUT MEDICAL JOURNAL | 2012年 / 03期
关键词
human papillomavirus infection; cervical cancer; morbidity; prevalence; vaccination;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The research aims at studying patterns and regional characteristics of morbidity and incidence of various papillomavirus infection and cervical cancer forms in the Republic of Sakha (Yakutia) in the pre-vaccination period and the first years of vaccination against this pathology. It is established that the studied periods do not show any significant differences or decreasing trend in anogenital (venereal) warts morbidity. The study revealed higher (by 1/6-2 times) incidence of high-risk HPV of type 16 in women, compared with men. There was no decrease in type 16 and 18 HPV incidence in 2008-2011 (the period of introducing low vaccination coverage), compared with the year 2007. There is a trend for increased CC morbidity in women aged 30-44 years.
引用
收藏
页码:118 / 125
页数:8
相关论文
共 10 条
  • [1] [Anonymous], 2001, CANC RES CANC CONTR
  • [2] The causal relation between human papillomavirus and cervical cancer
    Bosch, FX
    Lorincz, A
    Muñoz, N
    Meijer, CJLM
    Shah, KV
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) : 244 - 265
  • [3] Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
    Donovan, Basil
    Franklin, Neil
    Guy, Rebecca
    Grulich, Andrew E.
    Regan, David G.
    Ali, Hammad
    Wand, Handan
    Fairley, Christopher K.
    [J]. LANCET INFECTIOUS DISEASES, 2011, 11 (01) : 39 - 44
  • [4] HAUSEN HZ, 1989, CANCER RES, V49, P4677
  • [5] Lyalina L.V., 2005, EPIDEMIOLOGY VACCINA, V3, P31
  • [6] Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial
    Munoz, Nubia
    Manalastas, Ricardo, Jr.
    Pitisuttithum, Punee
    Tresukosol, Damrong
    Monsonego, Joseph
    Ault, Kevin
    Clavel, Christine
    Luna, Joaquin
    Myers, Evan
    Hood, Sara
    Bautista, Oliver
    Bryan, Janine
    Taddeo, Frank J.
    Esser, Mark T.
    Vuocolo, Scott
    Haupt, Richard M.
    Barr, Eliav
    Saah, Alfred
    [J]. LANCET, 2009, 373 (9679) : 1949 - 1957
  • [7] Shipulina O.Yu, 2009, P INT S PAP INF MAL, P44
  • [8] Stanley M., 2009, US OBSTETRICS GINECO, V4, P10
  • [9] Stern PL, 2009, VACCINES PREVENTION
  • [10] Urazova L.N., 2011, P 2 INT S PAP INF MA, P14